CWG needle controversy: CGF reprimands doctor, India escapes punishment

The Indian contingent will be served with a letter by the CWG 2018 officials for breaching 'no-needle policy' at games village

Medical device
Press Trust of India Gold Coast
Last Updated : Apr 03 2018 | 4:16 PM IST

The Indian boxing contingent on Monday heaved a sigh of relief after it escaped any major sanction for use of syringes at the Commonwealth Games village by its doctor Amol Patil, who was let off with a reprimand for not disposing the needles as per stipulated procedure.

Hearing a complaint filed by the Commonwealth Games Federation's medical commission, the CGF court ruled that Patil had erred in not disposing the syringes as mandated by the 'No Needle Policy' of the Games.

Patil had administered a vitamin B complex injection to an athlete who was feeling unwell.

"Under the No Needle Policy, needles are required to be stored in a central secured location, access to which is restricted to authorized medical personnel of the CGA delegation. The needles in question were not disposed of until he had made two trips to the Polyclinic," the CGF said in a statement.

"In the circumstances, the Federation Court's decision is that CGF should issue a strong written reprimand to the Doctor for the breaches.

"A copy of the letter of reprimand should be served on the Chef de Mission of the Indian Team who should be advised to ensure that no further infractions of CGF Policies occur by any member of the Indian Team," it added.

The CGF had stoically refused to name the national association or the athlete involved in the controversy which flared up after syringes were discovered at the Games Village on Saturday.

But speculation was rife that the country involved is India. The dope tests that followed the discovery of syringes, however, turned out negative.

"Upon questioning, the Doctor conceded that he was aware of the 'No Needle Policy' and subsequently detailed all use of needles for the period March 19 to date and co-operated in disclosing all medication in his possession," the CGF stated.

"The Federation Court found that there was a breach of Paragraphs I and II of the No Needle Policy in that the Doctor left needles in the room while he went to the Polyclinic to obtain sharp bins for the disposal of the needles," it added.

The CGF cleared Patil of violating the primary norms under the No Needle Policy which require that "whenever an athlete receives an injection, an Injection Declaration Form should be forwarded to the Commission no later than noon the day following such injection".

The CGF also took note of the bare minimum presence of doctors in the Indian contingent.

"The Indian Team comprises 327 persons in total with only one doctor (apart from the doctor assigned to Boxing) and one Physiotherapist. These are the first Games for both the Indian Chief Medical Officer and the Doctor in question," it said.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 03 2018 | 4:16 PM IST

Next Story